Premium
Autoantibodies to Human α6 Integrin in Patients with Bullous Pemphigoid
Author(s) -
KISS MÁRIA,
PERÉNYI ÁDÁM,
MARCZINOVITS ILONA,
MOLNÁR JÁNOS,
DOBOZY ATTILA,
KEMÉNY LAJOS,
HUSZ SÁNDOR
Publication year - 2005
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1196/annals.1361.051
Subject(s) - autoantibody , bullous pemphigoid , antibody , epitope , pemphigus vulgaris , immunology , integrin , recombinant dna , pemphigoid , medicine , antigen , pemphigus , biology , receptor , biochemistry , gene
A bstract : Bullous pemphigoid (BP) is characterized immunologically by tissue‐bound and circulating autoantibodies targeting the hemidesmosomal proteins BP230 and BP180. Recent evidence suggests a pathophysiological role for autoantibodies against α6 integrin in the subepidermal blister formation of oral pemphigoid. The objective of our study was to investigate the presence of anti‐α6 integrin antibodies in patients with classical BP. The autoantibody profiles of 30 patients with BP, 10 patients with pemphigus vulgaris, and 20 healthy persons were identified. With the use of PeptideStructure and PlotStructure software, four different antigenic epitopes for α6 integrin were predicted, and their fusion recombinant constructs were prepared in an E. coli expression system. Sera were tested for α6 integrin autoantibodies by an ELISA technique. Altogether, 52% of the patients with BP displayed circulating antibodies against at least one recombinant protein. Our findings provide the first evidence for the presence of anti‐α6 integrin antibodies in patients with classical BP.